These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 34862878)

  • 1. Effects of atorvastatin and Zishen Qingqi granules on immune function and liver function of patients with systemic lupus erythematosus with mild and moderate activity.
    Sun Y; Yuan L; Liu X; Yu W; Li J
    Pak J Pharm Sci; 2021 Sep; 34(5(Special)):2085-2090. PubMed ID: 34862878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of atorvastatin and Zishen Qingqi granules on immune function and liver function of patients with systemic lupus erythematosus with mild and moderate activity.
    Sun Y; Yuan L; Liu X; Yu W; Li J
    Pak J Pharm Sci; 2022 May; 35(3(Special)):931-936. PubMed ID: 35791590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atorvastatin therapy reduces interferon-regulated chemokine CXCL9 plasma levels in patients with systemic lupus erythematosus.
    Ferreira GA; Teixeira AL; Sato EI
    Lupus; 2010 Jul; 19(8):927-34. PubMed ID: 20410153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of atorvastatin on coronary calcifications and myocardial perfusion defects in systemic lupus erythematosus patients: a prospective, randomized, double-masked, placebo-controlled study.
    Plazak W; Gryga K; Dziedzic H; Tomkiewicz-Pajak L; Konieczynska M; Podolec P; Musial J
    Arthritis Res Ther; 2011 Jul; 13(4):R117. PubMed ID: 21774822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atorvastatin reduced soluble receptors of TNF-alpha in systemic lupus erythematosus.
    Ferreira GA; Teixeira AL; Calderaro DC; Sato EI
    Clin Exp Rheumatol; 2016; 34(1):42-8. PubMed ID: 26574625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secondary analysis of APPLE study suggests atorvastatin may reduce atherosclerosis progression in pubertal lupus patients with higher C reactive protein.
    Ardoin SP; Schanberg LE; Sandborg CI; Barnhart HX; Evans GW; Yow E; Mieszkalski KL; Ilowite NT; Eberhard A; Imundo LF; Kimura Y; Levy D; von Scheven E; Silverman E; Bowyer SL; Punaro L; Singer NG; Sherry DD; McCurdy DK; Klein-Gitelman M; Wallace C; Silver RM; Wagner-Weiner L; Higgins GC; Brunner HI; Jung L; Soep JB; Reed AM; Thompson SD;
    Ann Rheum Dis; 2014 Mar; 73(3):557-66. PubMed ID: 23436914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atorvastatin effect on systemic lupus erythematosus disease activity: a double-blind randomized clinical trial.
    Fatemi A; Moosavi M; Sayedbonakdar Z; Farajzadegan Z; Kazemi M; Smiley A
    Clin Rheumatol; 2014 Sep; 33(9):1273-8. PubMed ID: 24820145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atorvastatin-induced cholestatic hepatitis in a young woman with systemic lupus erythematosus. Grupo Lupus Virgen de las Nieves.
    Jiménez-Alonso J; Osorio JM; Gutiérrez-Cabello F; López de la Osa A; León L; Mediavilla García JD
    Arch Intern Med; 1999 Aug 9-23; 159(15):1811-2. PubMed ID: 10448788
    [No Abstract]   [Full Text] [Related]  

  • 9. Preliminary study of a traditional Chinese medicine formula in systemic lupus erythematosus patients to taper steroid dose and prevent disease flare-up.
    Liao YN; Liu CS; Tsai TR; Hung YC; Chang SJ; Lin HL; Chen YC; Lai HM; Yu SF; Chen CJ
    Kaohsiung J Med Sci; 2011 Jul; 27(7):251-7. PubMed ID: 21757141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atorvastatin and Aspirin as Adjuvant Therapy in Patients with SARS-CoV-2 Infection: A structured summary of a study protocol for a randomised controlled trial.
    Ghati N; Roy A; Bhatnagar S; Bhati S; Bhushan S; Mahendran M; Thakur A; Tiwari P; Dwivedi T; Mani K; Gupta R; Mohan A; Garg R; Saxena A; Guleria R; Deepti S
    Trials; 2020 Oct; 21(1):902. PubMed ID: 33126910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined mepacrine-hydroxychloroquine treatment in patients with systemic lupus erythematosus and refractory cutaneous and articular activity.
    Ugarte A; Porta S; Ríos R; Martinez-Zapico A; Ortego-Centeno N; Agesta N; Ruiz-Irastorza G
    Lupus; 2018 Sep; 27(10):1718-1722. PubMed ID: 29635998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycophenolate mofetil but not atorvastatin attenuates atherosclerosis in lupus-prone LDLr(-/-) mice.
    van Leuven SI; Mendez-Fernandez YV; Wilhelm AJ; Wade NS; Gabriel CL; Kastelein JJ; Stroes ES; Tak PP; Major AS
    Ann Rheum Dis; 2012 Mar; 71(3):408-14. PubMed ID: 21953346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atorvastatin therapy improves endothelial-dependent vasodilation in patients with systemic lupus erythematosus: an 8 weeks controlled trial.
    Ferreira GA; Navarro TP; Telles RW; Andrade LE; Sato EI
    Rheumatology (Oxford); 2007 Oct; 46(10):1560-5. PubMed ID: 17693444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The additive effects of hydroxychloroquine to maintenance therapy with standard of care in patients with systemic lupus erythematosus.
    Miyagawa I; Nakano K; Nakayamada S; Iwata S; Hanami K; Fukuyo S; Kubo S; Kawabe A; Miyazaki Y; Inoue Y; Ueno M; Ohkubo N; Fujita Y; Tanaka Y
    Int J Rheum Dis; 2020 Apr; 23(4):549-558. PubMed ID: 32020727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunomodulatory effects of atorvastatin on MRL/lpr mice.
    Sun J; Xu W; Wu Z; Cao C; Tan Y; Zhu M; Wu H; Yu J
    Adv Rheumatol; 2022 Dec; 62(1):47. PubMed ID: 36471414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sirolimus in patients with clinically active systemic lupus erythematosus resistant to, or intolerant of, conventional medications: a single-arm, open-label, phase 1/2 trial.
    Lai ZW; Kelly R; Winans T; Marchena I; Shadakshari A; Yu J; Dawood M; Garcia R; Tily H; Francis L; Faraone SV; Phillips PE; Perl A
    Lancet; 2018 Mar; 391(10126):1186-1196. PubMed ID: 29551338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Long-term efficacy of integrative medicine for treatment of systemic lupus erythematosus].
    Liu W; Liu XY; Zhang HB
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2009 Mar; 29(3):219-21. PubMed ID: 19548437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term atorvastatin therapy improves arterial stiffness of middle-aged systemic lupus erythematosus patients with pathological pulse wave velocity.
    Castejon R; Castañeda A; Sollet A; Mellor-Pita S; Tutor-Ureta P; Jimenez-Ortiz C; Yebra-Bango M
    Lupus; 2017 Apr; 26(4):355-364. PubMed ID: 27510602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of the therapy of amiodarone combined with atorvastatin on cardiac function of patients with acute myocardial infarction after percutaneous coronary intervention (PCI).
    Tu Y; Zhang J; Zhang M; Li Z; Zong W; Zhou Q
    Pak J Pharm Sci; 2021 Sep; 34(5(Special)):2035-2040. PubMed ID: 34862870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human Lupus Plasma Pro-Atherogenic Effects on Cultured Macrophages Are Not Mitigated by Statin Therapy: A Mechanistic LAPS Substudy.
    Reiss AB; Arain HA; Kasselman LJ; Renna HA; Zhen J; Voloshyna I; DeLeon J; Carsons SE; Petri M
    Medicina (Kaunas); 2019 Aug; 55(9):. PubMed ID: 31438615
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.